canada clinical guidance

Endometriosis — recognition, first-line management, referral

A Canadian clinical summary of endometriosis — recognition, first-line management, referral, with source-attributed priorities and explicit jurisdiction boundaries.

JurisdictionCanada
Source check2026-08-20
Clinical reviewiatroX editorial team · Clinical editorial review · reviewed 2026-08-20 · due 2027-08-20
AudienceHealthcare professionals practising in Canada
This is an iatroX educational summary of named Canada sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. The evidence source is pan-Canadian, but formularies, funded access, referral routes, public-health directions and service availability remain provincial or territorial.

Source and scope

This summary is bounded to the recommendations, population and decisions covered by Guideline No. 449: Diagnosis and Impact of Endometriosis – A Canadian Guideline. Apply it with the current provincial or territorial pathway where implementation differs.
sources for this section:SOGC 449

Source-attributed clinical priorities

  • Suspect endometriosis from cyclic or persistent pelvic pain, dysmenorrhea, dyspareunia, bowel or bladder symptoms and infertility impact.
  • A clinical or imaging diagnosis can support care; laparoscopy is not required as the first diagnostic step for every patient.
  • Discuss analgesic, hormonal, fertility and surgical options and refer complex, deep or refractory disease to experienced care.
  • A normal ultrasound does not exclude superficial endometriosis when the clinical pattern is convincing.
sources for this section:SOGC 449

Practical assessment and management workflow

1
Map cyclic and noncyclic pelvic pain, dyspareunia, bowel or bladder symptoms, bleeding, fertility and previous treatment.
2
Examine with consent and use pelvic ultrasound to identify endometrioma or deep disease when indicated.
3
Offer empiric analgesic and hormonal treatment when suitable while arranging specialist evaluation for complex disease.
4
Review pain, function, adverse effects and fertility goals and avoid repeated ineffective short trials.
sources for this section:SOGC 449

Safety, red flags and urgent escalation

  • Urgently assess acute severe pain, pregnancy, hemodynamic instability or possible torsion or rupture.
  • Refer ureteric, bowel or deep infiltrating disease to a team with appropriate surgical expertise.
  • Do not promise that hysterectomy alone will cure all endometriosis-related pain.
sources for this section:SOGC 449

Confirm the local pathway before acting

The evidence source is pan-Canadian, but formularies, funded access, referral routes, public-health directions and service availability remain provincial or territorial.
sources for this section:SOGC 449

Source and implementation boundary

Read this educational summary with the linked source, current Canadian product information where medicines are involved, and the applicable provincial or territorial pathway. Local formularies, reporting duties, referral routes and service availability can differ.
sources for this section:SOGC 449

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. Society of Obstetricians and Gynaecologists of CanadaGuideline No. 449: Diagnosis and Impact of Endometriosis – A Canadian Guidelineaccessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Found a source update or regional discrepancy? Tell the iatroX editorial team.